1 insider at Prenetics Global Limited (PRE) reported open-market stock purchases totaling $501,998 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from Yeung Danny Sheng Wu (director, officer: Chief Executive Officer), who acquired 11,181 shares at $21.40 on August 24, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-08-24 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 11,181 | $21.40 | $239,273 | SEC Form 4 |
| 2026-08-24 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 6,000 | $20.90 | $125,400 | SEC Form 4 |
| 2026-08-20 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 7,500 | $18.31 | $137,325 | SEC Form 4 |
Prenetics Global Limited is a Healthcare company in the Medical - Diagnostics & Research industry. It carried a market capitalization of about $371M, with shares trading near $21.82.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.